Uso terapêutico dos canabinoides em psiquiatria

The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial

(2010) Mark A. Ware et al.   ANESTHESIA AND ANALGESIA

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)

(2010) Jaime E. C. Hallak et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

[Commentary] TRIAL COMES TOO LATE AS PSYCHIATRIC SIDE EFFECTS END HOPE FOR RIMONABANT

(2009)   ADDICTION

A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain

(2009) Nancy A. Rigotti et al.   ADDICTION

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats

(2009) Leonardo B.M. Resstel et al.   BRITISH JOURNAL OF PHARMACOLOGY

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

(2009) TV Zanelati et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pharmacotherapy for Cannabis Dependence

(2009) Ryan Vandrey et al.   CNS DRUGS

Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology

(2009) S. Bhattacharyya et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabis and anxiety: a critical review of the evidence

(2009) José Alexandre Crippa et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia

(2009) Glenn Schwarcz et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances

(2009) Y. Ren et al.   JOURNAL OF NEUROSCIENCE

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease

(2009) Marcos Hortes Nisihara Chagas et al.   PARKINSONISM & RELATED DISORDERS

Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats

(2009) Daniel Thomas Malone et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

(2009) Alline Cristina Campos et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The psychiatric side-effects of rimonabant

(2009) Fabrício A. Moreira et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Magnetic resonance spectroscopy in anxiety disorders

(2008) Clarissa Trzesniak et al.   ACTA NEUROPSYCHIATRICA

Cannabis and psychiatric disorders: it is not only addiction

(2008) F. Markus Leweke et al.   ADDICTION BIOLOGY

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

(2008) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

(2008) Rafael M. Bitencourt et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia

(2008) Kirsten R Müller-Vahl et al.   Expert Review of Neurotherapeutics

Cannabidiol was ineffective for manic episode of bipolar affective disorder

(2008) AW Zuardi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabidiol for the treatment of psychosis in Parkinson’s disease

(2008) AW Zuardi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

(2008) Alline Cristina Campos et al.   PSYCHOPHARMACOLOGY

Structural magnetic ressonance imaging in anxiety disorders: an update of research findings

(2008) Maria Cecília Freitas Ferrari et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA